Does sex affect how patients respond to ASA?
- Aspirin appears to protect men and women differently. Chambers, Christopher V.; Russell, John J. // Patient Care;May2005, Vol. 39 Issue 5, p65
Provides information on a randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. Primary outcome of the trial; Comparison between the aspirin group and the placebo group; Effect of low-dose aspirin on stroke risk in women.
- Take an Aspirin and ... Buring, Julie; Ferrari, Nancy // Newsweek;4/24/2006, Vol. 147 Issue 17, p71
The article presents information about the benefits and risks of aspirin. The authors suggest that aspirin might help prevent clot-related cardiovascular events such as heart attack and stroke in both men and women. The authors note that while aspirin may reduce the chances of a recurrent...
- Low-dose aspirin lowered stroke risk but not risk for MI or cardiovascular death in women. // ACP Journal Club;Sep/Oct2005, Vol. 143 Issue 2, p33
The article presents an answer to a clinical question related to the effectiveness of low-dose aspirin for the primary prevention of cardiovascular disease in women. Women receiving aspirin and those receiving placebo did not differ for rates of a first major cardiovascular event, death from...
- Low dose aspirin lowered stroke risk but not risks of MI or cardiovascular deaths in women. Ridker, P. M.; Cook, N. R.; Lee, I. M.; Eikelboom, John W. // Evidence Based Medicine;Oct2005, Vol. 10 Issue 5, p137
The article discusses whether low dose aspirin is effective for the primary prevention of cardiovascular disease (CVD) in women. The Women's Health Study randomized almost 40,000 initially healthy women and, in contrast to previous trials, aspirin did not reduce myocardial infarction or death...
- Drugs for Cardiovascular Disease Prevention in Women: Implications of the AHA Guidelines Ã¢â‚¬â€œ 2007 Update. Wenger, Nanette K // Drugs;2008, Vol. 68 Issue 3, p339
Lifestyle interventions constitute the initial strategy for the primary and secondary prevention of cardiovascular disease in women. However, pharmacotherapy is often indicated for control of major cardiovascular risk factors, and abundant clinical trial data support the morbidity and mortality...
- Aspirin in women cuts CVD deaths. // Pulse;11/19/2005, Vol. 65 Issue 45, p12
The article reports that aspirin can cut death rates in postmenopausal women with cardiovascular disease.
- Effects of Aspirin Differ for Men and Women. // Access;Jul2005, Vol. 19 Issue 6, p12
Cites a study in the U.S. about the effects of low-dose aspirin therapy on women with different forms of cardiovascular disease. Number of major cardiovascular events for associated with the aspirin group; Risk reduction rate for all strokes; Prevalence of gastrointestinal bleeding requiring...
- Waistline may be predictor for CVD. Haigh, Christen // Endocrine Today;10/25/2008, Vol. 6 Issue 19, p24
The article reports on the higher risk for cardiovascular disease of women with larger waistlines.
- Without warning. Dortch, Irene Preston // Better Homes & Gardens;Sept2001, Vol. 79 Issue 9, p242
Focuses on the dangers and risks of heart diseases to women. Similarity of symptoms to those associated with men; Risk factors; Experiences of two women suffering from heart disease.